Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Next pandemic could be more lethal than COVID, vaccine creator says

Published 06/12/2021, 07:22
Updated 06/12/2021, 13:45
© Reuters. FILE PHOTO: People walk through Westminster Underground station during morning rush hour, amid the coronavirus disease (COVID-19) outbreak in London, Britain, December 1, 2021. REUTERS/Henry Nicholls

LONDON (Reuters) -Future pandemics could be even more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.

The novel coronavirus has killed 5.26 million people across the world, according to Johns Hopkins University, wiped out trillions of dollars in economic output and turned life upside down for billions of people.

"The truth is, the next one could be worse. It could be more contagious, or more lethal, or both," Sarah Gilbert said in the Richard Dimbleby Lecture, the BBC reported. "This will not be the last time a virus threatens our lives and our livelihoods."

Gilbert, a professor of vaccinology at the University of Oxford, said the world should make sure it is better prepared for the next virus.

"The advances we have made, and the knowledge we have gained, must not be lost," she said.

Efforts to end the COVID-19 pandemic have been uneven and fragmented, marked by limited access to vaccines in low-income countries while the "healthy and wealthy" in rich countries get boosters, health experts say.

A panel of health experts set up by the World Health Organisation to review the handling of the SARS-CoV-2 pandemic has called for permanent funding and for greater ability to investigate pandemics through a new treaty.

One proposal was for new financing of at least $10 billion a year for pandemic preparedness.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The COVID-19 outbreak was first detected in China in late 2019. Vaccines were developed against the virus in record time.

Gilbert said the Omicron variant's spike protein contained mutations known to increase the transmissibility of the virus.

"There are additional changes that may mean antibodies induced by the vaccines, or by infection with other variants, may be less effective at preventing infection with Omicron," Gilbert said.

"Until we know more, we should be cautious, and take steps to slow down the spread of this new variant."

Latest comments

oh the next one is already lined up-you can bet on it.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.